The present invention relates generally to the fields of genetics and medicine. More specifically, the present invention relates to improved methods of treating cancers using a TLR3 agonist, by assessing the expression of a TLR3 receptor by cancer cells.

 
Web www.patentalert.com

< Insulated gate field effect semiconductor devices and method of manufacturing the same

> Method of utilizing neurotrophins to manipulate reproductive capacity
~ 00436